Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan J Flach

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Survey of Ophthalmology|February 18, 2010
Nonsteroidal anti-inflammatory drugs in ophthalmologyStephen J Kim, Allan J Flach, Lee M Jampol
Journal of Psychopharmacology (Oxford, England)|October 16, 2014
Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trialAlan M Laties, Allan J Flach, Irina Baldycheva, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Survey of Ophthalmology|February 18, 2010
Nonsteroidal anti-inflammatory drugs in ophthalmologyStephen J Kim, Allan J Flach, Lee M Jampol
Journal of Psychopharmacology (Oxford, England)|October 16, 2014
Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trialAlan M Laties, Allan J Flach, Irina Baldycheva, et al.
Pageof 2